Home > Legislation > 115th Congress > H.R.1316

H.R.1316 - Prescription Drug Price Transparency Act115th Congress (2017-2018) |

Bill

Hide Overview
Sponsor: Rep. Collins, Doug [R-GA-9] (Introduced 03/02/2017)
Committees: House - Energy and Commerce; Ways and Means; Armed Services; Oversight and Government Reform
Latest Action: House - 04/05/2017 Referred to the Subcommittee on Military Personnel.  (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

Summary: H.R.1316 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.1316. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (03/02/2017)

Prescription Drug Price Transparency Act

This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.